DC Devices Inc. has closed a $34 million Series D financing round. Accelmed led the round with contributions from existing investors Third Rock Ventures, General Catalyst Partners and Lumira Capital, as well as a new undisclosed strategic investor. Funds will be used to complete clinical evaluation of the world’s first transcatheter device for the treatment of diastolic heart failure (DHF), a $5 billion global market opportunity.

July 11, 2014 — Cordis Corp. announced the launch of its Saber PTA (percutaneous transluminal angioplasty) dilatation catheter for the treatment of patients with peripheral arterial disease (PAD).

July 11, 2014 — On July 3, the Centers for Medicare & Medicaid Services (CMS) issued a proposed rule that would update payment policies and payment rates for services furnished under the Medicare Physician Fee Schedule (PFS) on or after Jan. 1, 2015.

July 11, 2014 — Toshiba America Medical Systems introduced its newest M-Power software version for the Vantage Titan 1.5T magnetic resonance (MR) system and a new software version for its Vantage Titan 3T MR. Toshiba will also offer the new software versions with enhanced automated tools at no charge to existing Titan customers with previous M-Power software versions that have a current service contract with Toshiba.

July 10, 2014 — 480 Biomedical announced it has been awarded Phase II funding from the National Heart, Lung, and Blood Institute (NHLBI) to continue the development of a bioresorbable, self-expanding scaffold to treat pediatric pulmonary artery stenosis (PAS).

July 10, 2014 — Life Recovery Systems announced the U.S. Food and Drug Administration (FDA) has approved two investigational device exemptions (IDEs) to study the use of the ThermoSuit system in the treatment of heart attack and ischemic stroke. Patients in both trials will be cooled while under sedation, with the intent of reaching a state of therapeutic hypothermia in approximately 30 minutes or less.

Orlando Heart Specialists (OHS) has added an 8th location in southwest Orlando, Fla. 

Biotronik announced that the first device patients to undergo full-body magnetic resonance imaging (MRI) scans in the United States have been implanted with the Biotronik DX System. 

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now